Middle Latency Somatosensory Evoked Potentials in Hemiparkinsonism

A. SOYSAL, F. ÖZER, B. ARPACI

Issue: 1999, Volume 5 - Issue 2
0 249

The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 266

Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 289

Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease

Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA

Issue: 1998, Volume 4 - Issue 3-4
0 288

H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease

Ayhan ÖZTÜRK, Hilmi UYSAL

Issue: 1998, Volume 4 - Issue 3-4
0 312

New Developments in Parkinson's Disease Management

M. Cenk AKBOSTANCI

Issue: 1998, Volume 4 - Issue 1-2
0 268

Clinical Scales for Multiple Sclerosis

Kadriye ARMUTLU, Rana KARABUDAK

Issue: 1997, Volume 3 - Issue 3-4
0 363

Carbon Monoxide Induced Parkinsonism: A Case Report.

Hülya APAYDIN, Aslı BOSTANCI, Sibel ÖZEKMEKÇİ

Issue: 1997, Volume 3 - Issue 1-2
0 335

P300 and P300 Topographic Mapping in Parkinson's Disease

Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU

Issue: 1995, Volume 1 - Issue 4
0 291

Hemiparkinsonism-Hemiatrophy syndrome-Case report

İhsan Özcan ERTÜRK, Münife MÜFTÜOĞLU

Issue: 1995, Volume 1 - Issue 3
0 239

THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS

Bülent ELİBOL

Issue: 1995, Volume 1 - Issue 1
0 292

Epigenetic analysis of heat shock activator complex in the peripheral blood of Parkinson's disease patients and its clinical significance

Yagmur İnalkac Gemici, Irem Tasci, Muhammed Dundar, Nazmi Ozgen, Nefsun Danis, Harika Gozde Gozukara, Ahmet Koc

DOI: 10.55697/tnd.2024.110

Issue: 2024, Volume 30 - Issue 2
963 639

Impact of a 12-week structured exercise program on motor function and exosomal alpha-synuclein levels in Parkinson's disease: A prospective analysis

Nihat Mustafayev, Abdulkadir Tunç, Birsen Elibol, Kamer Unal Eren, Sule Terzioglu-Usak

DOI: 10.55697/tnd.2024.8

Issue: 2024, Volume 30 - Issue 2
1718 865

Impulse control disorders related cognitive and behavioral features in Parkinson’s disease

Esra Erkoc Ataoglu, Yasemin Bozdağ, Ayse Bora Tokcaer

DOI: 10.55697/tnd.2024.109

Issue: 2024, Volume 30 - Issue 3
1131 684

Scale consistance in cognitive status awareness of patients with Parkinson’s disease

Sabiha Tezcan Aydemir, Elif Yüsra Unutmaz, Pınar Özkan, Talha Abalı, Gülnur Ayık, Dudu Genç Batmaz, Sema Nur Kibrit, Ahmet Veli Karacan, Müge Kuzu Kumcu, Merve Koç Yekedüz, Fatma Tuba Eminoğlu, Rezzak Yılmaz, Muhittin Cenk Akbostancı

DOI: 10.55697/tnd.2024.139

Issue: 2024, Volume 30 - Issue 3
689 415

Association of anticholinergic burden with Parkinson's disease severity and stage

Ümmü Serpil Sari, Süleyman Emre Koçyiğit

DOI: 10.55697/tnd.2024.167

Issue: 2024, Volume 30 - Issue 4
497 450

Distinguishing Alzheimer's disease from Parkinson's disease dementia using Enhanced Cued Recall test subscores

Ezgi Yetim, Ezgi Demirel, Ayse Akyay, Gul Yalcin Cakmakli, Esen Saka

DOI: 10.55697/tnd.2025.136

Issue: 2025, Volume 31 - Issue 1
399 212

Relationship between subjective sleep quality and serum ghrelin levels in Parkinson’s disease

Alper Ayaslı, Yıldız Değirmenci, Davran Fat, Mehmet Ali Sungur

DOI: 10.55697/tnd.2025.137

Issue: 2025, Volume 31 - Issue 1
272 178